Viatris Leads Global Efforts to Combat Antimicrobial Resistance and Expand Antibiotic Access
Antimicrobial resistance (AMR) poses a major global health threat, affecting millions of people worldwide and potentially causing even greater disruptions to healthcare if left unaddressed. AMR undermines the effectiveness of preventing and treating a growing number of infections caused by bacteria, viruses, parasites, and fungi.
Viatris has adopted a comprehensive strategy to combat AMR by ensuring access to over 90 antimicrobial medicines and through active collaboration with global partners. The company is a founding and board member of the AMR Industry Alliance (AMRIA), demonstrating its commitment to advancing sustainable solutions.
In 2024, the United Nations General Assembly held a high-level meeting among world leaders to secure strong political commitment against AMR, resulting in the adoption of the Political Declaration on AMR. As part of the global dialogue, Viatris, alongside Foreign Policy and other partners, co-hosted a simulation event titled “A World Without Antibiotics – Confronting the Global AMR Challenge.” The session brought together representatives from governments, industry, and civil society to explore strategies to prevent the catastrophic consequences of uncontrolled AMR. During the event, Viatris and AMRIA urged nations to ensure universal, equitable, affordable, and sustainable access to quality-assured antibiotics and diagnostics, while also addressing environmental factors that contribute to AMR.
As co-chair of the AMRIA Access Working Group, Viatris led the creation of the AMRIA Equitable and Responsible Access Roadmap, released in February 2024. Developed through a consultative, evidence-driven process, this roadmap serves as a global policy framework aimed at expanding equitable access to effective antibiotics. It identifies major barriers such as regulatory hurdles, limited diagnostic availability, and procurement challenges, and proposes actionable solutions to overcome them.
Promoting Scalable Models in the Fight Against AMR
In 2024, Viatris partnered with BBC Storyworks to highlight PLATINEA (PLATform for INnovation of Existing Antibiotics)—a pioneering multi-stakeholder initiative in Sweden that unites academia, healthcare institutions, public health authorities, payers, regulators, and the pharmaceutical industry to develop innovative approaches to combat AMR. The campaign showcased how the PLATINEA model could inspire similar collaborations across other regions, stimulating global discussions on scaling such initiatives to strengthen the worldwide response to antimicrobial resistance.
Viatris has adopted a comprehensive strategy to combat AMR by ensuring access to over 90 antimicrobial medicines and through active collaboration with global partners. The company is a founding and board member of the AMR Industry Alliance (AMRIA), demonstrating its commitment to advancing sustainable solutions.
In 2024, the United Nations General Assembly held a high-level meeting among world leaders to secure strong political commitment against AMR, resulting in the adoption of the Political Declaration on AMR. As part of the global dialogue, Viatris, alongside Foreign Policy and other partners, co-hosted a simulation event titled “A World Without Antibiotics – Confronting the Global AMR Challenge.” The session brought together representatives from governments, industry, and civil society to explore strategies to prevent the catastrophic consequences of uncontrolled AMR. During the event, Viatris and AMRIA urged nations to ensure universal, equitable, affordable, and sustainable access to quality-assured antibiotics and diagnostics, while also addressing environmental factors that contribute to AMR.
As co-chair of the AMRIA Access Working Group, Viatris led the creation of the AMRIA Equitable and Responsible Access Roadmap, released in February 2024. Developed through a consultative, evidence-driven process, this roadmap serves as a global policy framework aimed at expanding equitable access to effective antibiotics. It identifies major barriers such as regulatory hurdles, limited diagnostic availability, and procurement challenges, and proposes actionable solutions to overcome them.
Promoting Scalable Models in the Fight Against AMR
In 2024, Viatris partnered with BBC Storyworks to highlight PLATINEA (PLATform for INnovation of Existing Antibiotics)—a pioneering multi-stakeholder initiative in Sweden that unites academia, healthcare institutions, public health authorities, payers, regulators, and the pharmaceutical industry to develop innovative approaches to combat AMR. The campaign showcased how the PLATINEA model could inspire similar collaborations across other regions, stimulating global discussions on scaling such initiatives to strengthen the worldwide response to antimicrobial resistance.
Companies